NINDS to Fund Biomarker ID, Assay Optimization Studies for Parkinson's Disease | GenomeWeb

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will support research projects to discover and use biomarkers for Parkinson's disease, NINDS said in a new funding announcement on Monday.

NINDS plans to provide between $200,000 and $490,000 for two-to-three-year studies to discover biomarkers, optimize biomarker-based assays, and develop these tools further through replication studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.